NCT01915758View on ClinicalTrials.gov

W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 21, 2008

Primary Completion Date

February 20, 2009

Study Completion Date

February 20, 2009

Conditions
Acne Vulgaris
Interventions
DRUG

clindamycin1%/tretinoin 0.025% gel

clindamycin1%/tretinoin 0.025% gel

DRUG

vehicle gel

vehicle gel

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY